Naloxone Distribution Interactive Map
For questions about this data, email toda@dshs.texas.gov
Skip to Data SourceSummary
This map can be used to assist individuals in finding free naloxone closest to them.
Data source
Self-reported data collected from Naloxone Map Form submissions and responses from an emailed version of the survey.
Data Description
The Centers for Disease Control and Prevention (CDC) awarded Texas Department of State Health Services (DSHS) the Overdose Data to Action in States (OD2A-S) grant in September 2023 to create the Texas Overdose Data to Action (TODA) program. The Naloxone Distribution Interactive Map was created as a part of the TODA program’s prevention efforts to reduce fatal drug poisonings through increased access to naloxone. Naloxone can rapidly reverse opioid-involved drug poisonings. This includes opioids like heroin, fentanyl, and prescription opioid medications.1
Individuals can use this map to locate free naloxone (brand name – Narcan) closest to them by searching their address, city, zip code, or county. The free naloxone site types include: community health clinics, recovery support services, regional distribution sites, risk reduction groups, freestanding dispensers, and youth-based prevention services.
“Free Naloxone Sites Type” Descriptions- Community Health Clinic- community-based, patient-directed organization that provides affordable, accessible, and comprehensive primary healthcare services.
- Recovery Support Services- organization supporting recovery efforts by providing research-based treatment programs such as medications for opioid use disorder (MOUD), and/or a full range of human services that facilitate recovery and wellness contributing to an improved quality of life.
- Regional Distribution Site (Be Well)- program funded though University of Texas' Be Well program. This project is supported by Texas Targeted Opioid Response, a public health initiative operated by the Texas Health and Human Services Commission through federal funding from the Substance Abuse and Mental Health Services Administration grant award number H79TI085747. Additionally, this project is supported by the 88th General Appropriations Act Texas, under the bill pattern of House Bill Number 1.
- Risk Reduction Group- an organization incorporating community-driven public health strategies, including prevention tools, health promotion, and risk reduction.
- Freestanding Dispenser- a stand-alone unit containing naloxone (examples include vending machines, NaloxBox, wall-mounted cabinets, etc.).
- Youth-based Prevention Services- an organization providing services exclusively for individuals under the age of 18.
If there are no free naloxone distribution sites in an area, individuals may visit https://naloxonetexas.com/ to have naloxone shipped directly to their residence. They can also use the naloxone map form to learn more about becoming a naloxone distribution site or register an existing site not listed on the map.
This map also includes information about Over-the-Counter (OTC) Availability. The FDA approved naloxone for OTC use. Naloxone may be available for purchase at OTC places like pharmacies, convenience stores, or online. Most pharmacies now carry naloxone for a fee. Individuals may use the pharmacy map to locate their closest pharmacy to contact them to confirm cost and availability.
TODA regularly collects self-reported data from organizations that provide naloxone access to the public. Language used in this map is taken directly from survey responses.
Each resource listed on the map includes a “verified on” date, which is the specific date the information was confirmed as accurate. The map is updated monthly to add or revise information based on naloxone map form submissions.
Additional Information
To learn more about TODA, please visit https://www.dshs.texas.gov/injury-prevention/texas-overdose-data-action.
To register a site not listed on the map, learn more about distributing naloxone or submit questions/feedback, please visit https://txmch.gov1.qualtrics.com/jfe/form/SV_9XeskvSekT6bJaK.